Savas medis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,655,701 | 2,026,398 | 1,559,921 | 2,345,252 | 3,463,788 | 2,788,669 | 2,721,492 | 2,409,744 |
| Profit before tax | 67,004 | -72,331 | 11,910 | 208,984 | 862,968 | 112,299 | 121,938 | -101,533 |
| Net profit | 67,004 | -72,331 | 11,402 | 184,019 | 789,315 | 96,695 | 114,890 | -101,533 |
| Equity | 1,493,583 | 1,421,252 | 1,449,137 | 1,632,648 | 2,421,963 | 2,510,658 | 2,625,547 | 2,524,015 |
| Liabilities | 448,280 | 193,576 | 397,961 | 411,113 | 472,884 | 437,263 | 344,633 | 411,296 |
| Non-current assets | 1,385,462 | 1,264,208 | 1,425,580 | 1,228,483 | 1,704,455 | 1,950,217 | 2,097,379 | 1,860,269 |
| Current assets | 591,614 | 373,059 | 427,651 | 815,278 | 1,190,392 | 1,009,837 | 878,868 | 1,109,000 |
| Total assets | 1,977,076 | 1,637,267 | 1,853,231 | 2,043,761 | 2,894,847 | 2,960,054 | 2,976,247 | 2,969,269 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 435,109 | 355,513 | 317,197 |
| Social insurance contributions | - | - | - | - | - | 123,065 | 136,994 | 143,673 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.7% | -23.7% | -23.0% | +50.3% | +47.7% | -19.5% | -2.4% | -11.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.4% | -4.4% | 0.6% | 9.0% | 27.3% | 3.3% | 3.9% | -3.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.5% | -5.1% | 0.8% | 11.3% | 32.6% | 3.9% | 4.4% | -4.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.5% | -3.6% | 0.7% | 7.8% | 22.8% | 3.5% | 4.2% | -4.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.5% | -3.6% | 0.8% | 8.9% | 24.9% | 4.0% | 4.5% | -4.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 32,990 | 27,791 | 24,695 | 36,933 | 56,629 | 55,130 | 57,194 | 53,949 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Savas medis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-01-26 | 2023-01-31 | 1549.99 |
| 2023-01-17 | 2023-01-25 | 1378.97 |
| 2022-12-30 | 2023-01-15 | 1410.24 |
| 2022-12-16 | 2022-12-29 | 3410.24 |
| 2022-11-30 | 2022-12-14 | 3496.59 |
| 2022-11-21 | 2022-11-29 | 5496.59 |
| 2022-11-17 | 2022-11-18 | 5654.27 |
| 2022-10-31 | 2022-11-14 | 5548.75 |
| 2022-10-26 | 2022-10-30 | 7548.75 |
| 2022-10-24 | 2022-10-25 | 7467.12 |
| 2022-10-18 | 2022-10-23 | 7419.38 |
| 2022-09-30 | 2022-10-16 | 7472.12 |
| 2022-09-16 | 2022-09-29 | 9472.12 |
| 2022-08-30 | 2022-09-14 | 9504.23 |
| 2022-08-24 | 2022-08-29 | 11504.23 |
| 2022-08-23 | 2022-08-23 | 11551.97 |
| 2022-08-16 | 2022-08-22 | 843.61 |
| 2022-07-29 | 2022-08-15 | 11587.64 |
| 2022-07-28 | 2022-07-28 | 13584.48 |
| 2022-07-26 | 2022-07-27 | 13584.48 |
| 2022-07-25 | 2022-07-25 | 13386.62 |
| 2022-07-18 | 2022-07-24 | 13386.60 |
| 2022-07-15 | 2022-07-17 | 2232.61 |
| 2022-06-30 | 2022-07-14 | 13449.98 |
| 2022-06-16 | 2022-06-29 | 15449.98 |
| 2022-06-15 | 2022-06-15 | 4079.83 |
| 2022-05-31 | 2022-06-14 | 15462.01 |
| 2022-05-17 | 2022-05-30 | 17462.01 |
| 2022-05-13 | 2022-05-16 | 17542.02 |
| 2022-04-26 | 2022-05-12 | 17613.69 |
| 2022-04-22 | 2022-04-25 | 17443.68 |
| 2022-04-19 | 2022-04-21 | 19443.68 |
| 2022-04-15 | 2022-04-18 | 8488.28 |
| 2022-03-30 | 2022-04-14 | 19498.07 |
| 2022-03-16 | 2022-03-29 | 21498.07 |
| 2022-03-15 | 2022-03-15 | 11452.79 |
| 2022-02-25 | 2022-03-14 | 21607.80 |
| 2022-02-17 | 2022-02-24 | 23607.80 |
| 2022-02-15 | 2022-02-16 | 13708.46 |
| 2022-01-28 | 2022-02-14 | 23653.22 |
| 2022-01-26 | 2022-01-27 | 25653.22 |
| 2022-01-19 | 2022-01-25 | 25533.22 |
| 2022-01-18 | 2022-01-18 | 25533.22 |
| 2022-01-17 | 2022-01-17 | 14021.17 |
| 2021-12-29 | 2022-01-16 | 23844.47 |
| 2021-12-17 | 2021-12-28 | 25844.47 |
| 2021-12-16 | 2021-12-16 | 27533.22 |
| 2021-12-15 | 2021-12-15 | 15079.58 |
| 2021-12-10 | 2021-12-14 | 25870.85 |
| 2021-12-09 | 2021-12-09 | 26059.91 |
| 2021-11-30 | 2021-12-08 | 25914.30 |
| 2021-11-19 | 2021-11-29 | 27914.30 |
| 2021-11-16 | 2021-11-18 | 29646.50 |
| 2021-11-15 | 2021-11-15 | 17845.09 |
| 2021-11-05 | 2021-11-14 | 27964.47 |
| 2021-11-03 | 2021-11-04 | 27964.41 |
| 2021-10-26 | 2021-11-02 | 29964.41 |
| 2021-10-21 | 2021-10-25 | 29683.27 |
| 2021-10-18 | 2021-10-20 | 31415.47 |
| 2021-10-14 | 2021-10-17 | 18835.21 |
| 2021-09-29 | 2021-10-13 | 29724.39 |
| 2021-09-27 | 2021-09-28 | 31724.39 |
| 2021-09-16 | 2021-09-26 | 33456.59 |
Savas medis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 0.14 |
| 2025-09-19 | 2025-09-25 | 1.96 |
| 2025-03-28 | 2025-04-22 | 0.08 |
| 2025-03-20 | 2025-03-24 | 0.08 |
| 2025-02-28 | 2025-03-17 | 0.08 |
| 2025-02-20 | 2025-02-25 | 0.08 |
| 2025-02-05 | 2025-02-17 | 0.08 |
| 2024-12-14 | 2024-12-17 | 138.03 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Savas medis, UAB (code 158340478) is a private limited liability company engaged in logging. In 2025, the company generated €2.41M in revenue, down 11.5% year on year and 13.6% below the 2023 level of €2.79M. After net profit of €96.7K in 2023 and €114.9K in 2024, the company reported a net loss of €101.5K in 2025, with the profit margin moving to -4.2% from 3.5% and 4.2% in the previous two years. The 2025 balance sheet remained stable, with total assets of €2.97M, equity of €2.52M and liabilities of €411.3K. Equity accounted for 85.0% of assets, while debt to equity was 0.16 and asset turnover stood at 0.81x. Return on equity was -4.0% and return on assets -3.4% in 2025. Revenue per employee was €54.8K, while profit per employee was -€2.3K.